BORRONI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 21.251
EU - Europa 8.733
AS - Asia 5.495
AF - Africa 30
OC - Oceania 27
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 22
Totale 35.581
Nazione #
US - Stati Uniti d'America 21.210
CN - Cina 2.704
UA - Ucraina 2.375
DE - Germania 1.911
SG - Singapore 1.169
IT - Italia 1.078
HK - Hong Kong 927
PL - Polonia 802
GB - Regno Unito 649
FI - Finlandia 568
TR - Turchia 443
IE - Irlanda 426
FR - Francia 363
RU - Federazione Russa 246
IN - India 132
BE - Belgio 95
SE - Svezia 90
CZ - Repubblica Ceca 55
CA - Canada 34
VN - Vietnam 33
NL - Olanda 30
AU - Australia 26
EU - Europa 22
IR - Iran 18
MU - Mauritius 17
BR - Brasile 14
ES - Italia 12
ID - Indonesia 12
KR - Corea 9
JP - Giappone 8
RO - Romania 8
TH - Thailandia 6
TW - Taiwan 6
CL - Cile 5
LV - Lettonia 4
MA - Marocco 4
MY - Malesia 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
DK - Danimarca 3
EE - Estonia 3
KW - Kuwait 3
MX - Messico 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
AT - Austria 2
GR - Grecia 2
IL - Israele 2
MN - Mongolia 2
RS - Serbia 2
SL - Sierra Leone 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AW - Aruba 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 35.581
Città #
Fairfield 3.707
Woodbridge 2.816
Houston 1.876
Jacksonville 1.768
Ashburn 1.623
Seattle 1.438
Cambridge 1.344
Ann Arbor 1.321
Wilmington 1.236
Hong Kong 922
Singapore 883
Warsaw 801
Princeton 786
Nanjing 639
Chandler 626
Dublin 426
Istanbul 408
New York 399
Beijing 329
Dearborn 325
Helsinki 315
Nanchang 247
Brescia 220
Des Moines 175
Shenyang 175
San Diego 169
Changsha 153
Milan 150
Hebei 135
Shanghai 120
Jinan 119
Jiaxing 96
Tianjin 90
Brussels 88
Lancaster 87
Kunming 79
London 71
Boardman 63
Hangzhou 52
Ningbo 50
Los Angeles 49
Norwalk 48
Verona 47
Munich 45
San Mateo 45
Nürnberg 42
Zhengzhou 41
Romola 36
Taizhou 36
San Francisco 35
Guangzhou 31
Augusta 30
Dong Ket 30
Lanzhou 30
Rome 29
Olomouc 28
Brno 27
Toronto 26
Haikou 23
Leawood 22
Kilburn 21
Orange 20
Kocaeli 19
Fuzhou 18
Taiyuan 18
Frankfurt am Main 17
Hefei 16
Santa Clara 16
Lappeenranta 15
Mumbai 15
Ardabil 13
Chiswick 13
Monmouth Junction 13
Torino 13
Changchun 12
Jakarta 12
Redwood City 12
Bologna 10
Hounslow 10
Naples 10
Padova 10
Pune 10
Washington 10
Bergamo 9
Catania 9
Chicago 9
Gunzenhausen 9
Prescot 8
San Jose 8
São Paulo 8
Trieste 8
Acton 7
Falkenstein 7
Melbourne 7
Phoenix 7
Sydney 7
Wandsworth 7
Amsterdam 6
Cingia de' Botti 6
Lucca 6
Totale 27.478
Nome #
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. 230
The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. 215
Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. 206
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 202
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. 202
[(11)C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis 199
Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators 187
CSF Alzheimer's disease-like pattern in Corticobasal Syndrome: evidence for a distinct disorder. 181
"Alien face" in corticobasal degeneration syndrome: Extending clinical features [2] 179
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. 173
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 164
Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment 162
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 161
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 159
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 157
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration 155
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 155
Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia. 154
QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. 152
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlations 152
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. 149
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 148
Education plays a different role in Frontotemporal Dementia and Alzheimer's disease 145
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 145
COVID-19 impact on consecutive neurological patients admitted to the emergency department 145
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 144
Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease 144
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 144
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 144
A complicated case of intracranial hypotension: Diagnostic and management strategies 143
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 143
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration 140
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 139
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 135
Is early-onset clinicallydifferent from late-onset frontotemporal dementia? 133
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. 133
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy 132
EEG and granular osmiophilic elements in early-onset Alzheimer's disease. 129
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 129
Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidalsyndromes 126
A case report: doctor, my daughter has Alzheimer's disease. 125
The Speech and Language FOXP2 GeneModulates the Phenotype of Frontotemporal Lobar Degeneration 125
Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease. 125
Two Sequential Tc-99m ECD SPECT Studies in a Case of Sporadic Creutzfeldt–Jakob Disease Confirmed at Autopsy 124
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 124
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 123
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease 122
Autoimmunity and frontotemporal dementia 122
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 121
Survival in frontotemporal lobar degeneration and related disorders: latent class predictors and brain functional correlates 119
Prefrontal cortex rTMS enhances action naming in Progressive Non-Fluent Aphasia 119
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy. 118
Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training 118
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 118
Advances on biological markers in early diagnosis of Alzheimer disease 118
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 117
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 117
A complicated case of intracranial hypotension: diagnostic and management strategies. 116
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 116
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 116
Vascular risk factors and cognition in Parkinson's disease 115
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 114
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 114
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 114
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 114
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. 112
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? 112
Association between tau H2 haplotype and age at onset in frontotemporal dementia 111
Action and object naming in Parkinson's disease without dementia. 111
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins. 111
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 111
Beyond cognitive reserve: behavioural reserve hypothesis in Frontotemporal Dementia. 111
Understanding Emotions in Frontotemporal Dementia: The Explicit and Implicit Emotional Cue Mismatch. 111
VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. 110
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 110
Anodal transcranial direct current stimulation of parietal cortex enhances action naming in Corticobasal Syndrome. 109
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 109
Tau haplotype influences cerebral perfusion pattern in frontotemporal lobar degeneration and related disorders 108
Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling. 108
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. 108
Three sisters covering the transient global amnesia spectrum 107
ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects. 107
Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration 107
Pattern ofbehavioral disturbances in corticobasal degeneration syndrome and progressivesupranuclear palsy 107
Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. 106
Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. 105
C9orf72 repeat expansions are restricted to the ALS-FTD spectrum. 105
White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations. 105
Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C. 105
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 105
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. 104
The Neuroimaging Signature of Frontotemporal Lobar Degeneration Associated with Granulin Mutations: An Effective Connectivity Study 104
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 104
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 104
Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. 104
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort. 104
APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk 103
Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. 102
Functional and structural changes in Alzheimer’s disease and Mild Cognitive Impairment. Possible predictive role of QT Dispersion and Heart Rate Variability analisys 102
Acombination of CSF tau ratio and midsaggital midbraintopons atrophy for the earlydiagnosis of progressive supranuclear palsy 102
Totale 13.053
Categoria #
all - tutte 189.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.983 0 0 0 0 715 1.237 1.091 1.193 829 1.071 309 538
2020/20216.319 181 845 254 695 343 680 245 720 784 617 698 257
2021/20223.171 213 539 69 148 29 162 228 236 190 416 280 661
2022/20232.442 448 115 63 152 155 675 24 171 273 71 171 124
2023/20243.243 169 72 289 209 107 499 111 117 950 65 58 597
2024/20251.597 79 50 88 1.262 118 0 0 0 0 0 0 0
Totale 36.353